Stay updated on Pembrolizumab in MM Residual Disease Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.

Latest updates to the Pembrolizumab in MM Residual Disease Clinical Trial page
- ChecktodayChange DetectedThe page's related topics section no longer lists 'Multiple myeloma' and 'MedlinePlus Genetics', removing those topics from the study's contextual references.SummaryDifference0.2%

- Check8 days agoChange DetectedThe page now includes links to related topics for Multiple Myeloma and MedlinePlus Genetics, expanding access to contextual information about the disease on the study record.SummaryDifference0.2%

- Check15 days agoChange DetectedA new page revision label Revision: v3.6.6 was added, indicating an update to the page metadata. The older revision label Revision: v3.6.5 and several topic tags (Multiple myeloma, related topics:, MedlinePlus Genetics) were removed, reflecting a cleanup of non-core content rather than changes to study details.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now includes a 'Multiple myeloma' related topics section with a link to MedlinePlus Genetics, expanding cross-reference resources for readers.SummaryDifference0.2%

- Check36 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5, representing a minor version bump. This update aligns with backend or template changes rather than a modification to the study content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page's disease label 'Multiple myeloma' and the related topics section, including the MedlinePlus Genetics link, were removed, reducing disease-specific context and cross-references.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab in MM Residual Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in MM Residual Disease Clinical Trial page.